Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period

References

• Bauman BL, Ko JY, Cox S, et al. Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression – United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(19):1–11. doi: 10.15585/mmwr.mm6919a2.
   PubMed Web of Science ®Google Scholar
• Hessami K, Romanelli C, Chiurazzi M, et al. COVID-19 pandemic and maternal mental health: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022;35(20):4014–4021. doi: 10.1080/14767058.2020.1843155.
   PubMed Web of Science ®Google Scholar
• Caffieri A, Gómez-Gómez I, Barquero-Jimenez C, et al. Global prevalence of perinatal depression and anxiety during the COVID-19 pandemic: an umbrella review and meta-analytic synthesis. Acta Obstet Gynecol Scand. 2023;103(2):210–224. doi: 10.1111/aogs.14740.
   PubMed Web of Science ®Google Scholar
• Kyzar EJ, Purpura LJ, Shah J, et al. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav Immun Health. 2021;16:100315. doi: 10.1016/j.bbih.2021.100315.
   PubMedGoogle Scholar
• Goodman ML, Molldrem S, Elliott A, et al. Long COVID and mental health correlates: a new chronic condition fits existing patterns. Health Psychol Behav Med. 2023;11:2164498.
   PubMed Web of Science ®Google Scholar
• Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol. 2011;205(1):51.e1–51.e8. doi: 10.1016/j.ajog.2011.02.029.
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Palmsten K, Mogun H, et al. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry. 2013;35(3):265–271. doi: 10.1016/j.genhosppsych.2012.12.010.
   PubMed Web of Science ®Google Scholar
• Hayes RM, Wu P, Shelton RC, et al. Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies. Am J Obstet Gynecol. 2012;207(1):49.e1–49.e9. doi: 10.1016/j.ajog.2012.04.028.
   PubMed Web of Science ®Google Scholar
• Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194.e1–194.e5. doi: 10.1016/j.ajog.2007.07.036.
   PubMed Web of Science ®Google Scholar
• Ailes EC, Simeone RM, Dawson AL, et al. Using insurance claims data to identify and estimate critical periods in pregnancy: an application to antidepressants. Birth Defects Res. 2016;106(11):927–934. doi: 10.1002/bdra.23573.
   PubMedGoogle Scholar
• Hanley GE, Mintzes B. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth. 2014;14(1):242. doi: 10.1186/1471-2393-14-242.
   PubMedGoogle Scholar
• Oskotsky T, Marić I, Tang A, et al. Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open. 2021;4(11):e2133090. doi: 10.1001/jamanetworkopen.2021.33090.
   PubMed Web of Science ®Google Scholar
• Nakhaee H, Zangiabadian M, Bayati R, et al. The effect of antidepressants on the severity of COVID-19 in hospitalized patients: a systematic review and meta-analysis. PLOS One. 2022;17(10):e0267423. doi: 10.1371/journal.pone.0267423.
   PubMed Web of Science ®Google Scholar
• Rush RW, Keirse MJNC, Howat P, et al. Contribution of preterm delivery to perinatal mortality. Obstet Gynecol Surv. 1977;32(10):643–645. doi: 10.1097/00006254-197710000-00003.
   Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi: 10.1016/S0140-6736(08)60074-4.
   PubMed Web of Science ®Google Scholar
• Hamilton B, Martin J, Osterman M. VSRR 028: births: provisional data for 2022. U.S.: National Center for Health Statistics; 2023.
   Google Scholar
• Huybrechts KF, Sanghani RS, Avorn J, et al. Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLOS One. 2014;9(3):e92778. doi: 10.1371/journal.pone.0092778.
   PubMed Web of Science ®Google Scholar
• Sujan AC, Rickert ME, Öberg AS, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. Obstet Gynecol Surv. 2017;72(9):523–524. doi: 10.1097/01.ogx.0000524510.66825.09.
   Web of Science ®Google Scholar
• Yonkers KA, Norwitz ER, Smith MV, et al. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology. 2012;23(5):677–685. doi: 10.1097/EDE.0b013e31825838e9.
   PubMed Web of Science ®Google Scholar
• Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40(10):1723–1733. doi: 10.1017/S0033291709992194.
   PubMed Web of Science ®Google Scholar
• Källén B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004;158(4):312–316.
   PubMed Web of Science ®Google Scholar
• Nörby U, Forsberg L, Wide K, et al. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016;138(5):e20160181. doi: 10.1542/peds.2016-0181.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu Q, Cao S, et al. A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age. J Affect Disord. 2018;241:563–570.
   PubMed Web of Science ®Google Scholar
• Chang Q, Ma X-Y, Xu X-R, et al. Antidepressant use in depressed women during pregnancy and the risk of preterm birth: a systematic review and meta-analysis of 23 cohort studies. Front Pharmacol. 2020;11:659. doi: 10.3389/fphar.2020.00659.
   PubMed Web of Science ®Google Scholar
• Bandoli G, Chambers CD, Wells A, et al. Prenatal antidepressant use and risk of adverse neonatal outcomes. Pediatrics. 2020;146(1):e20192493. doi: 10.1542/peds.2019-2493.
   PubMed Web of Science ®Google Scholar
• Domingues RR, Wiltbank MC, Hernandez LL. Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation. Biol Reprod. 2023;109(1):17–28.
   PubMed Web of Science ®Google Scholar
• Rosenfeld CS. Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development. Biol Reprod. 2020;102(3):532–538. doi: 10.1093/biolre/ioz204.
   PubMed Web of Science ®Google Scholar
• Phillips GS, Wise LA, Rich-Edwards JW, et al. Prepregnancy depressive symptoms and preterm birth in the black women’s health study. Ann Epidemiol. 2010;20(1):8–15. doi: 10.1016/j.annepidem.2009.09.009.
   PubMed Web of Science ®Google Scholar
• Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod. 2008;24(1):146–153. doi: 10.1093/humrep/den342.
   PubMed Web of Science ®Google Scholar
• Amit G, Yanover C, Bivas-Benita M, et al. Antidepressant use during pregnancy and the risk of preterm birth – a cohort study. Research Square; 2023.
   Google Scholar
• Lennestål R, Källén B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol. 2007;27(6):607–613. doi: 10.1097/jcp.0b013e31815ac4d2.
   PubMed Web of Science ®Google Scholar
• Ericson A, Källén B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol. 1999;55(7):503–508.
   PubMed Web of Science ®Google Scholar
• Bandoli G, Kuo GM, Sugathan R, et al. Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period. Arch Womens Ment Health. 2018;21(4):411–419. doi: 10.1007/s00737-018-0809-2.
   PubMed Web of Science ®Google Scholar
• Wilkes S. The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis. 2008;3:45–53. doi: 10.2147/COPD.S1121.
   PubMedGoogle Scholar
• Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14:24–34.
   PubMedGoogle Scholar
• CDC/ATSDR SVI fact sheet [Internet]; 2023 [cited 2023 Dec 18]. Available from: https://www.atsdr.cdc.gov/placeandhealth/svi/fact_sheet/fact_sheet.html
   Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
   PubMed Web of Science ®Google Scholar
• Levis B, Sun Y, He C, et al. Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis. JAMA. 2020;323(22):2290–2300.
   PubMed Web of Science ®Google Scholar
• Löwe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95. doi: 10.1016/j.jad.2009.06.019.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW, et al. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–621.
   PubMed Web of Science ®Google Scholar
• King LS, Feddoes DE, Kirshenbaum JS, et al. Pregnancy during the pandemic: the impact of COVID-19-related stress on risk for prenatal depression. Psychol Med. 2023;53(1):170–180. doi: 10.1017/S003329172100132X.
   PubMed Web of Science ®Google Scholar
• Lantigua-Martinez M, Trostle ME, Torres AM, et al. Perinatal depression before and during the COVID-19 pandemic in New York city. AJOG Glob Rep. 2023;3(3):100253. doi: 10.1016/j.xagr.2023.100253.
   PubMedGoogle Scholar
• Ghazanfarpour M, Bahrami F, Rashidi Fakari F, et al. Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a meta-analysis. J Psychosom Obstet Gynaecol. 2022;43(3):315–326. doi: 10.1080/0167482X.2021.1929162.
   PubMed Web of Science ®Google Scholar
• Arzamani N, Soraya S, Hadi F, et al. The COVID-19 pandemic and mental health in pregnant women: a review article. Front Psychiatry. 2022;13:949239. doi: 10.3389/fpsyt.2022.949239.
   PubMed Web of Science ®Google Scholar
• Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Br J Psychiatry. 1987;150:782–786.
   PubMed Web of Science ®Google Scholar
• Malm H, Sourander A, Gissler M, et al. Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data. Am J Psychiatry. 2015;172(12):1224–1232. doi: 10.1176/appi.ajp.2015.14121575.
   PubMed Web of Science ®Google Scholar
• Gavin AR, Chae DH, Mustillo S, et al. Prepregnancy depressive mood and preterm birth in black and white women: findings from the CARDIA study. J Womens Health. 2009;18(6):803–811. doi: 10.1089/jwh.2008.0984.
   Web of Science ®Google Scholar
• Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012–1024. doi: 10.1001/archgenpsychiatry.2010.111.
   PubMed Web of Science ®Google Scholar
• Stephens MAC, Wand G. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res. 2012;34:468–483.
   PubMed Web of Science ®Google Scholar
• Najafzadeh A. Stress and preterm birth: biological and vascular mechanisms affecting the feto-placental circulation and the length of gestation. Sonography. 2016;3(3):95–102. doi: 10.1002/sono.12073.
   Google Scholar
• Liu Y-Z, Wang Y-X, Jiang C-L. Inflammation: the common pathway of stress-related diseases. Front Hum Neurosci. 2017;11:316. doi: 10.3389/fnhum.2017.00316.
   PubMed Web of Science ®Google Scholar
• Grigoriadis S. Antenatal depression: pregnancy and neonatal outcomes [Internet]. UpToDate; 2023 [cited 2024 Jan 3]. Available from: https://www.uptodate.com/contents/antenatal-depression-pregnancy-and-neonatal-outcomes
   Google Scholar
• Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63(8):898–906.
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Qiu C, Ornoy A, et al. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Obstet Anesth Dig. 2011;31(1):46–47. doi: 10.1097/01.aoa.0000393180.98348.f6.
   Google Scholar
• Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009;163(10):949–954. doi: 10.1001/archpediatrics.2009.164.
   PubMedGoogle Scholar
• Colvin L, Slack-Smith L, Stanley FJ, et al. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res. 2011;91(3):142–152. doi: 10.1002/bdra.20773.
   Google Scholar
• Davis RL, Rubanowice D, McPhillips H, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug. 2007;16(10):1086–1094. doi: 10.1002/pds.1462.
   PubMed Web of Science ®Google Scholar
• Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154–166.
   PubMed Web of Science ®Google Scholar
• Chan J, Natekar A, Einarson A, et al. Risks of untreated depression in pregnancy. Can Fam Physician. 2014;60:242–243.
   PubMed Web of Science ®Google Scholar